Filleron, Thomas <br/><br/>
Failure event types and prognostic factors after node-positive breast cancer in patients treated by adjuvant chemotherapy: impact on follow-up.  [electronic resource] 

 -  Bulletin du cancer  Jun 2012 
 - E64-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1769-6917 
<br/><br/><label>Standard No.: </label>10.1684/bdc.2012.1592  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Docetaxel<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Lymph Nodes<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Mitoxantrone--administration & dosage<br/>Neoplasm Recurrence, Local--mortality<br/>Prognosis<br/>Randomized Controlled Trials as Topic<br/>Taxoids--administration & dosage<br/>Treatment Failure